Clinical Trials

140 enrolled

Advanced Solid Tumour

NCT06783647 2026-05-18

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

230 enrolled

Advanced Solid Tumour

NCT07331155 2026-05-18

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

110 enrolled

Advanced Solid Tumour

NCT05170958 2026-05-15

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

396 enrolled

Advanced Solid Tumor

NCT07390383 2026-05-13

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Phase 1/2 Active not recruiting

Advanced Solid Tumour

NCT05438329 2026-05-12

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

1,123 enrolled

Phase 1 Active not recruiting

Advanced Solid Tumor

NCT05906537 2026-05-12

SKB410 for Injection in Solid Tumors

54 enrolled

Advanced Solid Tumors

NCT06474455 2026-05-11

A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors

156 enrolled

Advanced Solid Tumors

NCT05367635 2026-05-08

A Study of SKB315 in Patients With Advanced Solid Tumors

246 enrolled

Advanced Solid Tumors

NCT06428331 2026-05-08

A Study of SKB518 in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumors

NCT06826040 2026-05-08

SKB445 for Injection in Solid Tumors

126 enrolled

Advanced Solid Tumors

NCT07087197 2026-05-08

A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

90 enrolled

Metastatic Solid Tumors

NCT07480733 2026-05-08

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

480 enrolled

Phase 2 Active not recruiting

Advanced Malignant Solid Tumors

NCT06927687 2026-04-29

Study of ZG005 in Patients With Advanced Solid Tumors

50 enrolled

Advanced Solid Tumor

NCT06132828 2026-04-27

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

216 enrolled

Solid Tumor

NCT07529535 2026-04-17

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

Phase 1 Suspended

16 enrolled

Advance Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

326 enrolled

Solid Tumors

NCT05879627 2026-04-13

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Phase 1 Terminated

93 enrolled

Advanced Solid Tumors

NCT07326488 2026-04-13

A Study of MHB009C in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT07509684 2026-04-13

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

190 enrolled

Advanced Solid Tumors

NCT07192107 2026-04-09

A Study of MHB042C in Patients With Advanced Solid Tumors

200 enrolled

Advanced Malignant Solid Tumor

NCT07192120 2026-04-09

A Study of MHB048C in Patients With Advanced Solid Tumors

GenitourinaryOther solid neoplasm

200 enrolled

mCRPC (Metastatic Castration-resistant Prostate Cancer)

NCT07514975 2026-04-09

First-In-Human Study of KHN922 for Injection

276 enrolled

Advanced Solid Tumors Cancer

NCT07512583 2026-04-06

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

178 enrolled

Advanced Solid Tumor

NCT05848466 2026-03-30

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Phase 1 Completed

23 enrolled

Advanced or Metastatic Solid Tumors

NCT07222969 2026-03-23

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

146 enrolled

Phase 1/2 Active not recruiting

Advanced Solid Tumors

NCT06057922 2026-03-12

A Study YL201 in Patients With Selected Advanced Solid Tumors

990 enrolled

Advanced Solid Tumor

NCT07069062 2026-03-09

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

261 enrolled

Phase 1 Not yet recruiting

Solid Tumor

NCT07434609 2026-02-25

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

150 enrolled

Advanced Solid Tumor (Phase 1)

NCT05620017 2026-02-09

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

182 enrolled

Advanced Solid Tumors

NCT06792552 2026-01-29

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

414 enrolled

Advanced Solid Tumors

NCT07275242 2026-01-15

A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

107 enrolled

Solid Tumor

NCT04284488 2026-01-08

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

Phase 1/2 Terminated

40 enrolled

Advanced Solid Tumor

NCT04175847 2026-01-07

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1/2 Completed

198 enrolled

Solid Tumor

NCT06298058 2026-01-07

A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.

144 enrolled

Advanced Solid Tumor

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

67 enrolled

Solid Tumor

NCT05378737 2026-01-06

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Phase 1 Completed

216 enrolled

Advanced Solid Tumors

NCT05584800 2026-01-05

Study of ZGGS18 in Patients With Advanced Solid Tumors

222 enrolled

Advanced Solid Tumor

NCT06938880 2026-01-05

Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors

60 enrolled

Advanced Solid Tumor

NCT07252414 2026-01-05

GenSci143 in Participants With Advanced Solid Tumors

180 enrolled

Advanced Solid Tumors

NCT07251166 2025-12-24

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid Tumors

170 enrolled

DermatologicGastrointestinalOther solid neoplasmThoracic

Advanced Solid Tumors

NCT05047536 2025-12-19

KZR-261 in Subjects With Advanced Solid Malignancies

Phase 1 Terminated

61 enrolled 25 charts

Uveal Melanoma, Melanoma, Mesothelioma, Neoplasm Metastasis, Colorectal Neoplasms

NCT07229586 2025-12-19

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

100 enrolled

Solid Tumor

NCT06840821 2025-12-02

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

156 enrolled

Advanced Solid Tumors

NCT07105215 2025-11-26

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

312 enrolled

Solid Tumors

NCT07083323 2025-11-25

A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors

262 enrolled

Advanced Solid Tumor

NCT07249892 2025-11-25

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

195 enrolled

Metastatic Solid Tumors

NCT06238401 2025-11-24

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

77 enrolled

Advanced Solid Tumors

NCT07126665 2025-11-18

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

116 enrolled

Advanced Malignant Solid Tumor

NCT07130383 2025-11-18

A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors